Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327829 · ClinicalTrials.gov registry record · Early Phase 1
Stimulating After Recovery From Traumatic Brain Injury
A Early Phase 1 study of TBI (Traumatic Brain Injury), sponsored by University of Minnesota.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05327829: Recruiting Early Phase 1 study of TBI (Traumatic Brain Injury), sponsored by University of Minnesota.
NCT05327829 is a Early Phase 1 study of TBI (Traumatic Brain Injury) that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 172-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05327829, a Early Phase 1 study of TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.
Primary Outcome
Using non-invasive transcranial alternating current stimulation, it will be determined if this study is feasible for improving cognitive recovery after mild to moderate brain injury. To determine the sum total of completion rate of study procedures.
Conditions Studied
Interventions
- COMBINATION_PRODUCT External non-invasive stimulation
- BEHAVIORAL COGED
Study Locations (1)
Minnesota
- Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2028-01-15 |
| Phase | Early Phase 1 |
What NCT05327829 shows while recruiting
NCT05327829 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 172-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (83% lower).
The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 2 interventions - of which External non-invasive stimulation is the first listed.
NCT05327829 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05327829 about?
NCT05327829 is a clinical study titled "Stimulating After Recovery From Traumatic Brain Injury". This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.
What is the current status of trial NCT05327829?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2025-01-15. Estimated completion is 2028-01-15.
What conditions does trial NCT05327829 study?
This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).
What interventions are being tested in trial NCT05327829?
The interventions under investigation include: External non-invasive stimulation (COMBINATION_PRODUCT), COGED (BEHAVIORAL).
Who is sponsoring clinical trial NCT05327829?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05327829 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for TBI (Traumatic Brain Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05327829's enrollment target sits among peer trials
30 19th of 20 higher than 2 of 20 other TBI (Traumatic Brain Injury) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other TBI (Traumatic Brain Injury) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
RECRUITING · NA
-
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Well-being Interventions in Adults With TBI
RECRUITING · NA
-
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
RECRUITING · NA
-
Evaluation of Decision-Making Fatigue After Traumatic Brain Injury
RECRUITING · NA
-
Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI